Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Madan Jagasia

8 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    NMDPBMT0346

    07/09/2003

    Repository for National Donor Program (NMDP) Research Blood Samples.

    Other

    VICCBMT1401

    08/29/2014

    Prospective Outcomes of Second-Line Therapy in Acute Graft-versus-Host Study Including ECP (POSTAGE)

    Other

    VICCBMT1158

    10/20/2011

    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and other Indications

    Treatment

    VICCBMT16137

    05/05/2017

    A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

    Treatment

    VICCBMT16110

    03/10/2017

    A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

    Treatment

    VICCBMT1662

    03/10/2017

    A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients with Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease

    Treatment

    VICCBMT1661

    11/30/2016

    A Phase 2a, Dose-Escalation, Open-Label Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects with Chronic Graft Versus Host Disease

    Treatment

    VICCBMT1651

    09/30/2016

    Optimizing Post-Allogeneic Hematopoietic Cell Transplant Outcomes for Lymphoma Using Ibrutinib


    Print this page for your doctor